Variations in Surgeon Treatment Recommendations for Lobectomy in Early-Stage Non-Small-Cell Lung Cancer by Patient Age and Comorbidity
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Prior research suggests that older patients are less likely to undergo resection of early-stage non-small-cell lung carcinomas (NSCLCs). We surveyed surgeons to understand how their recommendations for lobectomy were influenced by age, the presence and severity of smoking-related lung disease, or by characteristics of the surgeons and their practices.
We surveyed surgeons caring for NSCLC patients regarding whether they would recommend lobectomy for hypothetical patients with early-stage NSCLC who varied by age (55 vs. 80 years) and comorbid illness (none, moderate, severe chronic obstructive pulmonary disease [COPD]). Ordinal logistic regression was used to identify the importance of patient, surgeon, and practice characteristics on surgery recommendations.
Surgeons recommended lobectomy for nearly all patients who were 55 years old with no comorbidity (adjusted proportion 98.6%), 55 years old with moderate COPD (adjusted proportion 97.8%), or 80 years old with no comorbidity (adjusted proportion 98.1%). Fewer recommended lobectomy for 80-year-old patients with moderate COPD (adjusted proportion 82.3%), and far fewer recommended lobectomy for severe COPD, irrespective of age (adjusted rate 18.7% for the 55-year-old patient and 6.1% for the 80-year-old patient) (P < 0.002). Surgeons who enroll patients onto clinical trials (P = 0.03) were more likely than others to recommend lobectomy, but no other surgeon characteristic predicted recommendations.
Lower rates of lobectomy among older patients do not seem to be explained by age-related biases among surgeons for otherwise healthy patients.
- American Cancer Society. Cancer facts and figures, 2008. Atlanta, GA: American Cancer Society; 2008.
- Reis L, Eisner M, Kosary C. SEER cancer statistics review, 1973–1998. Bethesda, MD: National Cancer Institute; 2001.
- Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K, American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. 2nd ed. Chest. 2007;132(3 Suppl):234S–42S.
- NCCN Practice Guidelines in Oncology, Non-Small Cell Lung Cancer, version 2. 2009. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 7 Apr 2009.
- Boffa DJ, Allen MS, Grab JD, et al. Data from the society of thoracic surgeons general thoracic surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008;135:247–54. CrossRef
- Manser R, Wright G, Hart D, Byrnes G, Campbell DA. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev. 2005;CD004699.
- Wright G, Manser RL, Byrnes G, Hart D, Campbell DA. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax. 2006;61:597–603. CrossRef
- Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer. 2007;110:1532–41. CrossRef
- Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132:193–9. CrossRef
- Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev. 2001;CD002935.
- Weinmann M, Jeremic B, Toomes H, Friedel G, Bamberg M. Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer. Lung Cancer. 2003;39:233–53. CrossRef
- Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996;9:7–10. CrossRef
- Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg. 1983;86:654–8.
- Ishida T, Yokoyama H, Kaneko S, Sugio K, Sugimachi K. Long-term results of operation for non-small cell lung cancer in the elderly. Ann Thorac Surg. 1990;50:919–22. CrossRef
- Sherman S, Guidot CE. The feasibility of thoracotomy for lung cancer in the elderly. JAMA. 1987;258:927–30. CrossRef
- Jaklitsch MT, Mery CM, Audisio RA. The use of surgery to treat lung cancer in elderly patients. Lancet Oncol. 2003;4:463–71. CrossRef
- Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the Surveillance, Epidemiology, and End Results database. Chest. 2005;128:237–45. CrossRef
- Brock MV, Kim MP, Hooker CM, et al. Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience. Ann Thorac Surg. 2004;77:271–7. CrossRef
- Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. Eur J Cardiothorac Surg. 2005;28:380–3. CrossRef
- Morandi U, Stefani A, Golinelli M, et al. Results of surgical resection in patients over the age of 70 years with non small-cell lung cancer. Eur J Cardiothorac Surg. 1997;11:432–9. CrossRef
- Port JL, Korst RJ, Lee PC, et al. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg. 2005;79:1686–90. CrossRef
- Nugent WC, Edney MT, Hammerness PG, et al. Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment. Ann Thorac Surg. 1997;63:193–7. CrossRef
- Peake MD, Thompson S, Lowe D, Pearson MG, Participating C. Ageism in the management of lung cancer. Age Ageing. 2003;32:171–7. CrossRef
- Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2004;22:2992–6. CrossRef
- He Y, Zaslavsky AM, Harrington DP, Catalano PJ, Landrum MB. Multiple imputation in a large-scale complex survey: a practical guide. Stat Methods Med Res. (in press).
- Little RJ, Rubin DB. Statistical analysis with missing data. 2nd ed. New York: Wiley; 2002.
- Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail and high-risk patients: a case-control study. Ann Thorac Surg. 1999;68:194–200. CrossRef
- Demmy TL, Plante AJ, Nwogu CE, Takita H, Anderson TM. Discharge independence with minimally invasive lobectomy. Am J Surg. 2004;188:698–702. CrossRef
- Reilly JJ Jr, Mentzer SJ, Sugarbaker DJ. Preoperative assessment of patients undergoing pulmonary resection. Chest. 1993;103(4 Suppl):342S–5S. CrossRef
- Cain HD, Stevens PM, Adaniya R. Preoperative pulmonary function and complications after cardiovascular surgery. Chest. 1979;76:130–5. CrossRef
- Peabody JW, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141:771–80.
- Variations in Surgeon Treatment Recommendations for Lobectomy in Early-Stage Non-Small-Cell Lung Cancer by Patient Age and Comorbidity
Annals of Surgical Oncology
Volume 17, Issue 6 , pp 1581-1588
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery and Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, USA
- 2. Department of Medical Oncology and the Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA, USA
- 3. Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
- 4. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
- 5. RAND Corporation, Santa Monica, CA, USA
- 6. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
- 7. Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA, USA
- 8. College of Pharmacy, University of Iowa, Iowa City, IA, USA
- 9. Division of General Internal Medicine, Brigham and Women’s Hospital, Boston, MA, USA